Aurinia Pharmaceuticals (AUPH) Precio de Acción, Cotización, Noticias e Historial | Benzinga

Aurinia Pharmaceuticals Inc (AUPH) Precio de Acción, Cotización, Noticias e Historial

AUPHNASDAQ

Trade with Public

Trade with Public

$16.90

0.160.96%

Últ. Act.: Oct 21, 5:44 PM

$17.02

0.281.67%

Panorámica generalNoticias Previsión de beneficios Eventos Precios objetivo Finanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Estadísticas Clave

Apertura

$16.73

Cierre

$16.90

Volumen / Prom.

783.24K / 966.27K

Rango diario

$16.63 - $17.01

Rango de 52 semanas

11.39 - 19.25

Capitalización bursátil

$2.26B

Ratio PER

7.34

Rentabilidad por dividendo

-

Exchange

NASDAQ

RSI

58

Interés en corto

6.57%

Días para cubrir

9.38

Noticias Recientes de Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug

Aurinia Pharmaceuticals shares rise after settling patent litigation with Teva, which can launch generic voclosporin no earlier than December 2036.

Vandana Singh

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Aurinia Pharmaceuticals shares are trading higher Monday after announcing a leadership transition seen as a sign of continuity and strategy.

Henry Khederian

Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets

Aurinia Pharmaceuticals shares are trading lower Thursday afternoon after the lupus-focused drugmaker posts a blowout fourth quarter and raises expectations for continued growth in 2026.

Henry Khederian

FDA Drug Chief George Tidmarsh Resigns After Allegations Of Power Misuse

FDA drug center head George Tidmarsh resigned after accusations of misusing power to harm a former business associate. He denies wrongdoing.

Vandana Singh

US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert

U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in premarket.

Rishabh Mishra

Finanzas

Trimestral

Anual

Nombre

Ingresos Variación
Bruto Variación
EBITDA Variación
EBIT Variación
Beneficios Variación

Flujos de Caja

Flujo de Caja Operativo (TTM)

175.24M

Flujo de Caja de Inversión (TTM)

12.84M

Flujo de Caja de Financiación (TTM)

-61.25M

Flujo de Caja Libre (TTM)

175.07M

Gasto de Capital (TTM)

-176.00K

Cambio Neto en Efectivo (TTM)

126.83M

Tendencia de los analistas

0

0

0

0

ago

1

oct

Compra

Mantener

Venta

Venta fuerte

Calificación de analistas

2.9

Mantener

Compra fuerte

Compra

Mantener

Venta

Venta fuerte

Métricas de Valoración

Valor Empresarial

$1.85B

Relación P/E (TTM)

7.34

Relación P/E (FWD)

11.74

Relación PEG (TTM)

-

Relación P/S (TTM)

7.33

Relación P/B (TTM)

3.62

Rendimiento de Ganancias % (TTM)

13.62%

Rendimiento de Ganancias % (FWD)

8.52%

EV / EBITDA (TTM)

10.06

Precio / EBITDA (TTM)

12.42

Precio / Flujo de Caja Libre (TTM)

13.04

Valor Contable / Acción

$4.62

Deuda Empresarial

Deuda Total

-

Deuda a Largo Plazo

-

Emisión de Deuda a Largo Plazo (TTM)

-

Reembolso de Deuda a Largo Plazo (TTM)

-$13.99M

Efectivo Total

$179.83M

Deuda a Capital

0.10

Emisión de Deuda (TTM)

-$13.99M

Reembolso de Deuda (TTM)

-$13.99M